• Bookmarks

    Bookmarks

  • Concepts

    Concepts

  • Activity

    Activity

  • Courses

    Courses


Mycobacterium tuberculosis is the bacterium responsible for tuberculosis, a contagious disease primarily affecting the lungs but capable of spreading to other organs. It is characterized by its slow growth, unique cell wall structure, and ability to evade the host's immune system, making it a challenging pathogen to treat and control.
Pulmonary tuberculosis is a contagious bacterial infection caused by Mycobacterium tuberculosis, primarily affecting the lungs and characterized by symptoms like chronic cough, fever, and weight loss. Effective treatment typically involves a prolonged course of antibiotics, and prevention relies heavily on public health measures and vaccination with the BCG vaccine.
Extrapulmonary tuberculosis (EPTB) refers to tuberculosis infections that occur outside the lungs, affecting organs such as lymph nodes, pleura, genitourinary tract, bones, and meninges. Diagnosis and treatment of EPTB can be challenging due to its diverse manifestations and often requires a combination of clinical, radiological, and microbiological assessments.
Latent tuberculosis infection (LTBI) occurs when a person is infected with Mycobacterium tuberculosis, but the bacteria remain inactive and cause no symptoms. While individuals with LTBI are not contagious, they can develop active tuberculosis if the immune system becomes weakened, so monitoring and treatment are crucial to prevent progression.
The Tuberculin skin test, also known as the Mantoux test, is a diagnostic tool used to detect latent or active tuberculosis infection by measuring the immune response to an intradermal injection of purified protein derivative (PPD). A positive result indicates TB exposure, but further testing is required to confirm active disease, as false positives can occur due to prior Bacillus Calmette-Guérin (BCG) vaccination or infection with non-tuberculous mycobacteria.
Interferon-gamma release assays (IGRAs) are blood tests used to detect latent tuberculosis infection by measuring the immune response to specific antigens associated with Mycobacterium tuberculosis. They offer advantages over the traditional tuberculin skin test, including higher specificity and no requirement for a return visit to interpret results.
Antitubercular therapy refers to the treatment regimen used to combat tuberculosis, primarily involving a combination of antibiotics to ensure the complete eradication of Mycobacterium tuberculosis and prevent drug resistance. The standard therapy often includes the use of isoniazid, rifampicin, ethambutol, and pyrazinamide over a period of six months or more, depending on the patient's response and the presence of drug-resistant strains.
Drug-resistant tuberculosis is a form of tuberculosis that does not respond to the standard treatments due to resistance to one or more of the primary anti-TB drugs. This poses a significant public health challenge as it requires longer, more complex, and often less effective treatment regimens, increasing the risk of transmission and mortality.
Directly observed therapy (DOT) is a healthcare strategy where a healthcare provider or trained individual observes patients as they take their medications to ensure adherence, particularly used in the treatment of tuberculosis and other chronic conditions. This approach helps improve treatment outcomes by reducing the risk of drug resistance and ensuring completion of therapy.
The BCG vaccine, primarily used against tuberculosis, is derived from a strain of Mycobacterium bovis and has been in use since the early 20th century. Though it provides variable efficacy against pulmonary tuberculosis, it is more effective in preventing severe forms of the disease in children, such as tuberculous meningitis and miliary disease.
Breastfeeding contraindications are specific medical or situational factors that make breastfeeding unsafe or inadvisable for either the mother or the infant. Understanding these contraindications is essential for ensuring the health and safety of both parties involved in the breastfeeding process.
Tuberculosis treatment regimen typically involves a combination of antibiotics taken over a period of 6 to 9 months to effectively eradicate the Mycobacterium tuberculosis bacteria and prevent the development of drug-resistant strains. Adherence to the regimen is crucial to prevent relapse and transmission, necessitating patient education and sometimes directly observed therapy (DOT) to ensure compliance.
HIV and tuberculosis (TB) co-infection is a significant public health challenge because HIV weakens the immune system, increasing the risk of active TB in infected individuals, while TB can accelerate the progression of HIV. Effective management requires integrated treatment strategies that address both infections simultaneously to reduce morbidity and mortality rates.
Tuberculosis (TB) transmission occurs primarily through airborne particles when an infected person coughs, sneezes, or speaks, allowing the bacteria to enter the lungs of another person. Effective control measures include early detection, isolation of infectious cases, and adherence to treatment regimens to prevent further spread.
3